Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stabilityIan Sellitto, Bertrand Le Bourdonnec, Karin Worm, et al.Science Translational Medicine|March 8, 2019
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growthTroy E Messick, Garry R Smith, Samantha S Soldan, et al.Nature Metabolism|July 23, 2020
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restrictionTingting Wang, J N Rashida Gnanaprakasam, Xuyong Chen, et al.Nature Communications|June 2, 2025
Loss of CD98HC phosphorylation by ATM impairs antiporter trafficking and drives glutamate toxicity in Ataxia telangiectasiaJuly Carolina Romero, Sonal S Tonapi, Manish Parihar, et al.Biorxiv : the Preprint Server for Biology|September 16, 2024
Molecular glues that inhibit deubiquitylase activity and inflammatory signallingFrancesca Chandler, Poli Adi Narayana Reddy, Smita Bhutda, et al.Nature Structural & Molecular Biology|March 18, 2025
Molecular glues that inhibit deubiquitylase activity and inflammatory signalingFrancesca Chandler, Poli Adi Narayana Reddy, Smita Bhutda, et al.Journal of Medicinal Chemistry|September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.Pageof 9